RCE recce pharmaceuticals ltd

Ann: Positive Sinusitis Patient Update - Special Access Scheme, page-80

  1. 5,482 Posts.
    lightbulb Created with Sketch. 705
    I wonder how they plan to price this product should it get to market. They have stated the ingredients are cheap and plentiful I believe. Will they price it as a "last resort" treatment that we know will work if all else fails and is kept in reserve. Or will they price it in such a way that it becomes the primary treatment for target infections like sinusitis etc. Maybe they plan different marketing plans for simpler things like burns and sinusitis but maybe sepsis will be more of a last resort. Just speculating and dreaming of the day we have products in the market. The recent SAS treatment of recurring sinusitis seems like an incredible step forward.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
30.0¢
Change
-0.010(3.23%)
Mkt cap ! $86.51M
Open High Low Value Volume
30.5¢ 32.0¢ 29.5¢ $30.88K 101.2K

Buyers (Bids)

No. Vol. Price($)
2 21103 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.0¢ 15000 1
View Market Depth
Last trade - 15.59pm 26/06/2025 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.